Sign in
4

Changes in Ownership

X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-036471

Chief Financial Officer acquired 230,645 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mostafa Adam S. Chief Financial Officer 2023-10-31 Grant or award +230,645 310,866 D
Loading xslF345X05/wk-form4_1698959058.xml…